Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-05

Clinical Trial Update: The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating androgen and growth hormone effects on height and learning in girls with Turner syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androgen
  • Growth Hormone (somatropin)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Turner Syndrome | Phase 3 | Status: COMPLETED